Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06399627
Other study ID # 4-2022-1112
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2016
Est. completion date May 31, 2024

Study information

Verified date April 2024
Source Yonsei University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a single center retrospective study of patients who underwent off pump coronary artery bypass surgery between 2016.11~2023.05. From this patient group, preoperatively non-anemic patients were selected and were divided into 2 cohorts according to their preoperative iron status; iron replete and iron deficient. These two cohorts were compared to evaluate the effect of preoperative iron deficiency on patient outcomes. The primary end point was the occurrence of composite morbidity/mortality end points which were: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction. Occurrence of any one of these outcomes counted as primary end point met. Secondary outcome was to evaluate and compare hemoglobin recovery of iron replete and deficient patients until one year after surgery.


Recruitment information / eligibility

Status Recruiting
Enrollment 433
Est. completion date May 31, 2024
Est. primary completion date May 31, 2024
Accepts healthy volunteers No
Gender All
Age group 29 Years to 85 Years
Eligibility Inclusion Criteria: - Patients who received off pump coronary artery bypass surgery (OPCAB) between 2016.11.01-2023.05.31 Exclusion Criteria: - preoperative anemia (male Hb <13g/dL, female Hb<12g/dL) - emergency surgery - redo-off pump coronary artery bypass surgery - minimally invasive coronary artery bypass surgery - OPCAB in conjunction with other cardiac surgical procedures (e.g. valve surgery, graft replacement surgery of the aorta) - intraoperative on pump conversion - lack of sufficient preoperative data (ferritin, transferrin saturation, C-reactive protein) to determine iron status - administration of intravenous iron within 4 weeks or parenteral iron of more than 2 weeks prior to surgery - enrollemnt in other clinical studies

Study Design


Locations

Country Name City State
Korea, Republic of Yonsei University Health system, Severance Hospital Seoul

Sponsors (1)

Lead Sponsor Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type Measure Description Time frame Safety issue
Primary Number of participants with in hospital mortality, stroke, deep sternal infection, hemostatic reoperation, delirium This outcome is a composite of the following: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction. The occurrence of any one of these was regarded as primary end point met. from the end of surgery until patient discharge (assessed up to day 60)
Primary Number of participants with acute kidney injury This outcome is a composite of the following: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction. The occurrence of any one of these was regarded as primary end point met. until 7 days after surgery
Primary Number of participants with post operative myocardial infarction This outcome is a composite of the following: in hospital mortality, acute kidney injury (AKI), stroke, deep sternal infection, hemostatic reoperation, prolonged mechanical ventilation of more than 24hours, delirium and postoperative myocardial infarction. The occurrence of any one of these was regarded as primary end point met. until 48 hours post-surgery
Secondary Post discharge hemoglobin Data of hemoglobin levels after discharge until 1 year after surgery was collected to evaluate hemoglobin recovery to preoperative baseline levels. Until 1 year after surgery